Brugada syndrome: Risk stratification and prevention of sudden cardiac death

被引:2
|
作者
Eckardt L. [1 ]
机构
[1] Klinik für Kardiologie II – Rhythmologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, Münster
关键词
Implantable cardioverter-defibrillator; Ion-channelopathy; Risk stratification; ST-segment elevations; Ventricular tachycardia;
D O I
10.1007/s00399-020-00667-x
中图分类号
学科分类号
摘要
Brugada syndrome is ion channelopathy defined by coved type ST-elevation in at least one right precordial ECG lead. Patients may suffer from ventricular tachycardia/fibrillation, which may cause syncope or sudden cardiac death. The majority of patients are likely to remain asymptomatic throughout life. A correct ECG diagnosis remains challenging. The implantable cardioverter/defibrillator (ICD) is the only established therapy to protect against sudden cardiac death. Thus, individual risk stratification is of major clinical relevance in primary prevention. The present article gives an update on current risk stratification and novel therapeutic options apart from ICD therapy. © 2020, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
引用
收藏
页码:39 / 47
页数:8
相关论文
共 50 条
  • [41] Sudden death in hypertrophic cardiomyopathy - Risk stratification and prevention
    Valgaeren, G
    Conraads, V
    Colpaert, C
    Rademakers, F
    Vrints, C
    ACTA CARDIOLOGICA, 1998, 53 (01) : 23 - 29
  • [42] Sudden Cardiac Death in the General Population: Can We Improve Risk Stratification and Prevention?
    Murray, Gary L.
    Colombo, Joseph
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2021, 30 (04) : 271 - 276
  • [43] Risk Stratification for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Reply Letter
    Piva e Mattos, Beatriz
    Scolari, Fernando Luis
    Garbin, Henrique Ianhke
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 117 (01) : 158 - 159
  • [44] Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy
    Miller, Marc A.
    Gomes, J. Anthony
    Fuster, Valentin
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (12): : 667 - 676
  • [45] RISK STRATIFICATION OF SUDDEN CARDIAC DEATH IN HYPERTROPHIC CARDIOMYOPATHY
    Ghannam, Michael
    Parsh, Jessica
    Oral, Hakan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 2280 - 2280
  • [46] Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy
    Marc A Miller
    J Anthony Gomes
    Valentin Fuster
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 667 - 676
  • [47] Optimization Model for Risk Stratification of Sudden Cardiac Death
    Kaminski, Marek
    Kotas, Rafal
    Mazur, Piotr
    Sakowicz, Bartosz
    Napieralski, Andrzej
    MIXED DESIGN OF INTEGRATED CIRCUITS AND SYSTEMS, MIXDES 2013, 2013, : 553 - 561
  • [48] Risk Stratification for Sudden Cardiac Death A Plan for the Future
    Goldberger, Jeffrey J.
    Basu, Anirban
    Boineau, Robin
    Buxton, Alfred E.
    Cain, Michael E.
    Canty, John M., Jr.
    Chen, Peng-Sheng
    Chugh, Sumeet S.
    Costantini, Otto
    Exner, Derek V.
    Kadish, Alan H.
    Lee, Byron
    Lloyd-Jones, Donald
    Moss, Arthur J.
    Myerburg, Robert J.
    Olgin, Jeffrey E.
    Passman, Rod
    Stevenson, William G.
    Tomaselli, Gordon F.
    Zareba, Wojciech
    Zipes, Douglas P.
    Zoloth, Laurie
    CIRCULATION, 2014, 129 (04) : 516 - 526
  • [49] Role of risk stratification and genetics in sudden cardiac death
    Rai, Vikrant
    Agrawal, Devendra K.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2017, 95 (03) : 225 - 238
  • [50] Prevalence of brugada pattern and brugada syndrome in the apparently normal population and in trained athletes at high risk of sudden cardiac death
    Melnic, M.
    Stoian, I.
    Serban, I.
    Macarie, C.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 : S89 - S89